Female testosterone is a low-concentration hormone, so the same number can mean different things depending on cycle day, SHBG, contraception and the assay used. Here is how I read these results in real clinical practice.
- Typical total testosterone in adult women is roughly 15–70 ng/dL, or 0.5–2.4 nmol/L, but the lab method can shift the range.
- Free testosterone is often about 0.1–6.4 pg/mL in many adult female reference intervals; low SHBG can make free testosterone high even when total testosterone looks normal.
- Cycle timing can raise testosterone around ovulation by about 10–30%, so repeat testing is best done on a similar cycle day.
- Combined birth control pills commonly raise SHBG and may lower free testosterone by about 50–60%, so the result can look artificially low.
- Menopause does not make testosterone disappear; total testosterone usually falls gradually, while free testosterone may rise if SHBG drops.
- LC-MS/MS testing is preferred for women because many routine immunoassays are less accurate at low female testosterone concentrations.
- High-risk results include total testosterone above 150–200 ng/dL or DHEA-S above about 700 µg/dL, especially with rapid voice, hair or muscle changes.
- A normal result still needs clinical context if symptoms, SHBG, DHEA-S, LH, FSH, estradiol, prolactin, TSH or insulin markers point in another direction.
What is the usual testosterone normal range for women?
The usual testosterone normal range for women is about 15–70 ng/dL for total testosterone and about 0.1–6.4 pg/mL for free testosterone, but those numbers are not universal. As of June 13, 2026, I would not interpret a female testosterone result without age, cycle day, SHBG, medication history and assay method.
A result of 48 ng/dL can be normal in a 28-year-old on cycle day 14, more suspicious in a 62-year-old with new facial hair, and misleadingly low in someone taking a combined oral contraceptive. That is why our biomarker guide treats testosterone as a pattern marker, not a stand-alone verdict.
Kantesti is an AI blood test analyzer that reads female testosterone levels alongside SHBG, albumin, estradiol, LH, FSH, DHEA-S and metabolic markers when those values are available. In our analysis of 2M+ blood tests across 127+ countries, the most common mistake is assuming the lab’s green range equals the patient’s true clinical range.
I am Thomas Klein, MD, and in my clinical reviews I usually ask three questions before reacting to a female testosterone result: was it measured by LC-MS/MS, was SHBG abnormal, and was the patient using hormones in the prior 8–12 weeks? If any answer is yes, the printed reference interval may be only the beginning.
How female testosterone levels change by age
Female testosterone levels are lowest in childhood, rise through puberty, peak in early adult life, and then usually decline slowly rather than suddenly. A practical testosterone normal range by age must separate teenagers, reproductive-age adults, perimenopausal women and older women.
For many adult women aged 20–39, total testosterone around 15–70 ng/dL is within the expected interval when measured with a reliable assay. By the 60s and 70s, some healthy women sit closer to 7–40 ng/dL, especially if SHBG is high or body weight is low.
Age is not just a calendar issue. A 35-year-old endurance athlete with low energy availability, ferritin of 14 ng/mL and missed periods may have a testosterone of 12 ng/dL for a very different reason than a 72-year-old with the same value; our women’s life-stage checklist is built around that distinction.
Teenage ranges are the messiest. Puberty, acne treatments, weight change and irregular ovulation can move total testosterone from under 10 ng/dL to the adult range within a few years, so pediatric or adolescent reference intervals should be used rather than adult cutoffs.
How menstrual phase and time of day affect results
Testosterone in women can rise around ovulation and may vary modestly across the day, so repeat results should be compared at a similar cycle phase and time. A mid-cycle testosterone value can be about 10–30% higher than an early follicular value in some ovulatory women.
If a patient tests on day 3 one month and day 14 the next, a change from 32 to 43 ng/dL may be physiology rather than disease. I usually prefer early follicular testing, roughly cycle days 2–5, when the question is acne, hirsutism or irregular periods.
Ovulation status matters more than many lab portals admit. A progesterone level drawn about 7 days before the expected period can confirm whether a cycle was ovulatory, which is why I often pair testosterone review with progesterone timing rather than reading androgens alone.
Morning testing is still sensible, even though female testosterone has a smaller daily rhythm than male testosterone. If the first sample was taken at 08:00 fasting and the repeat at 16:30 after poor sleep, a 15–25% shift is not shocking.
Why total testosterone, free testosterone and SHBG can disagree
Total testosterone measures bound plus unbound hormone, while free testosterone estimates the small biologically active fraction. SHBG is the main reason a woman can have normal total testosterone but high free testosterone.
A typical nonpregnant adult SHBG range is roughly 30–120 nmol/L, although laboratories vary. When SHBG falls to 15–25 nmol/L, a total testosterone of 45 ng/dL may produce a free testosterone result that behaves like androgen excess.
The opposite happens with high SHBG. A woman taking estrogen-containing contraception may have total testosterone of 38 ng/dL but very low free testosterone because SHBG is 180 nmol/L; our guide to free versus total testosterone explains why the two numbers can point in different directions.
Free androgen index, calculated as total testosterone in nmol/L divided by SHBG in nmol/L multiplied by 100, is sometimes used when calculated free testosterone is unavailable. An FAI above about 5 can support biochemical androgen excess, but it becomes unreliable when SHBG is extremely low or the testosterone assay is weak.
What menopause does to testosterone results
Menopause usually changes female testosterone gradually, not overnight. Estradiol drops sharply, but testosterone production from adrenal and ovarian tissue tends to decline over years, which is why a postmenopausal result still needs context.
A postmenopausal total testosterone of 18–35 ng/dL can be entirely normal, especially without new hair growth, acne or scalp hair thinning. In my experience, the more revealing change is often SHBG: it may fall with insulin resistance or weight gain, raising free testosterone even as total testosterone looks ordinary.
Surgical menopause is different. Removal or loss of ovarian hormone production can reduce circulating testosterone by roughly 40–50% in some women, and symptoms may appear faster than after natural menopause; readers tracking broader changes may find our menopause marker guide useful.
The evidence on testosterone treatment after menopause is narrower than marketing claims suggest. The Global Consensus Position Statement led by Davis et al. in 2019 found the clearest evidence only for carefully selected postmenopausal women with hypoactive sexual desire disorder, not for general fatigue, weight gain or mood symptoms.
For a deeper clinical background on ovulation, menopause and hormone symptoms, our women’s health guide pulls together the patterns we see repeatedly in blood test interpretation.
How birth control, pregnancy and medicines shift testosterone
Combined estrogen-containing contraception usually raises SHBG and lowers free testosterone, while progestin-only methods have more variable effects. Pregnancy, anti-androgen medicines, steroids, anticonvulsants and thyroid medication changes can also make female testosterone results hard to compare.
The 2014 systematic review by Zimmerman et al. found that combined oral contraceptives lowered free testosterone substantially, with many estimates near a 50–60% reduction, while SHBG rose significantly. That effect is not a lab error; it is the expected binding-protein response to estrogen exposure.
I do not compare testosterone drawn while taking a combined pill with testosterone drawn 4 weeks after stopping it. SHBG can remain elevated for 8–12 weeks, so a result during that window may still reflect the prior medication rather than the patient’s baseline; this same timing issue comes up in perimenopause testing.
Pregnancy is its own physiology. Total testosterone may rise several-fold because SHBG rises and placental metabolism changes, so nonpregnant reference ranges should not be used to diagnose androgen excess in pregnancy.
Why the lab assay method may matter more than the flag
LC-MS/MS is generally the preferred method for measuring total testosterone in women because female concentrations are low. Many routine immunoassays were built around higher male ranges and can be inaccurate near 10–70 ng/dL.
Rosner et al. warned in the Endocrine Society position statement that testosterone measurement is especially vulnerable to error in women and children, where concentrations sit near the lower end of many assays. A difference of 10 ng/dL may be meaningful by LC-MS/MS and mostly noise on a poorer immunoassay.
Kantesti is an AI lab test interpretation service that checks whether the report names LC-MS/MS, chemiluminescent immunoassay, direct free testosterone or calculated free testosterone when that information is printed. Our methodology pages on clinical validation explain why assay metadata changes the confidence level of an interpretation.
Direct free testosterone immunoassays are a particular trap. If the free testosterone result conflicts with calculated free testosterone, SHBG, symptoms and total testosterone, I usually trust the broader pattern before trusting one isolated direct free value.
Some European labs report total testosterone in nmol/L, while many US reports use ng/dL. To convert total testosterone from ng/dL to nmol/L, multiply by 0.0347; 50 ng/dL is about 1.7 nmol/L.
When high testosterone suggests PCOS or adrenal causes
Mildly high testosterone in women most often points to PCOS, low SHBG or medication effects, while very high levels raise concern for adrenal or ovarian androgen excess. Total testosterone above 150–200 ng/dL deserves prompt medical evaluation, especially if symptoms are new or rapidly progressive.
PCOS usually produces mild to moderate androgen elevation rather than extreme numbers. A total testosterone of 75–110 ng/dL, low SHBG, irregular cycles and insulin resistance fit a common PCOS pattern, particularly when DHEA-S is not severely elevated.
DHEA-S helps localize the source because it is made mainly by the adrenal glands. A DHEA-S above about 700 µg/dL, or a testosterone above 150–200 ng/dL, is not a watch-and-wait result in a woman with rapid hirsutism, voice deepening or new muscle changes.
I also check 17-hydroxyprogesterone when symptoms began young or androgen levels are higher than expected. For a fuller pattern-based approach, see our PCOS lab guide, which separates testosterone, insulin, LH/FSH and prolactin clues.
Why a normal testosterone result can still need review
A normal total testosterone result can still need review when symptoms suggest androgen excess or deficiency. The most common reason is that total testosterone hides changes in free testosterone caused by abnormal SHBG.
One patient I reviewed had total testosterone of 42 ng/dL, which looked normal, but SHBG was 18 nmol/L and calculated free testosterone was high. Her acne and chin hair made sense only after we stopped staring at total testosterone alone.
Another blind spot is tissue sensitivity. Some women have normal circulating testosterone but increased local androgen action in hair follicles or skin glands; that is why acne, scalp hair thinning and hirsutism sometimes outpace the lab flag.
When symptoms and the lab disagree, I look for insulin resistance, thyroid disease, prolactin elevation, ferritin deficiency and recent hormone exposure. Our article on high free testosterone goes deeper into the SHBG-low, free-testosterone-high pattern that basic panels often miss.
What low testosterone means in women
Low testosterone in women is harder to define than high testosterone because there is no universally accepted diagnostic cutoff for symptoms. A total testosterone below about 15 ng/dL may be low for many adult women, but treatment decisions should not be based on that number alone.
Fatigue, low libido, low mood and reduced muscle strength are nonspecific symptoms. I have seen women blamed for low testosterone when the real drivers were ferritin of 9 ng/mL, TSH of 6.2 mIU/L, vitamin D deficiency or chronic under-eating.
Davis et al. in 2019 concluded that no blood testosterone cutoff reliably diagnoses female sexual dysfunction. That is a crucial point: the lab can support a clinical picture, but it cannot prove that testosterone is the cause of low desire or low energy.
DHEA-S adds context because it reflects adrenal androgen production and falls with age. If both testosterone and DHEA-S are low, our DHEA blood test guide can help frame whether the pattern is age-related, medication-related or worth endocrine review.
Which follow-up labs help interpret female testosterone
The most useful follow-up labs for female testosterone are SHBG, albumin, DHEA-S, androstenedione, LH, FSH, estradiol, prolactin, TSH and metabolic markers such as fasting glucose, HbA1c or fasting insulin. These tests separate hormone production from hormone binding and tissue context.
If total testosterone is high, I want SHBG and calculated free testosterone first. If DHEA-S is also high, the pattern shifts toward adrenal contribution; if LH is high relative to FSH with irregular cycles, PCOS becomes more plausible.
Kantesti AI interprets female testosterone results by grouping androgen markers with thyroid, prolactin, glucose and lipid data when they appear on the same report. Kantesti is an AI biomarker interpretation platform used by patients who need context across panels, not just a red or green flag.
A practical starting panel is total testosterone by LC-MS/MS, SHBG, albumin, DHEA-S, androstenedione, LH, FSH, estradiol, prolactin and TSH. For broader pattern reading, our hormone panel guide shows why clinicians rarely stop at one hormone.
How to prepare for a testosterone blood test
For the most comparable female testosterone result, test in the morning, use the same lab when possible, record cycle day, and list hormonal medicines or supplements. Do not stop prescribed contraception, steroids or endocrine medicine without the clinician who prescribed it.
I usually recommend a 07:00–10:00 sample for repeat testosterone testing, especially when the prior result was borderline. Fasting is not always required, but fasting keeps insulin and triglyceride context cleaner if those markers are drawn at the same visit.
Biotin is a sneaky issue. High-dose biotin, often 5–10 mg daily in hair and nail supplements, can interfere with some immunoassays, so many clinics ask patients to stop it for 48–72 hours before testing if medically safe.
If you start or stop a combined contraceptive, wait about 8–12 weeks before treating the testosterone result as a new baseline. Our testosterone test prep article covers sleep, exercise, fasting and medication timing in more detail.
How Kantesti AI reads testosterone in clinical context
Kantesti AI reads testosterone by combining the number, unit, reference interval, assay clue, age, sex, SHBG, related hormones and trend history when those details are available. This reduces the risk of overreacting to a technically normal but clinically mismatched result.
A single testosterone value has a weak signal-to-noise ratio in women because the range is narrow and assays vary. Kantesti’s neural network therefore checks whether a 58 ng/dL result sits beside SHBG of 22 nmol/L, HbA1c of 5.9%, LH/FSH imbalance or a prior result of 24 ng/dL.
Kantesti is an AI-powered blood test analysis tool used by 2M+ people in 75+ languages, and our platform is designed to flag patterns that deserve human review rather than pretending a lab value is a diagnosis. The technical design is described in our AI technology guide.
Privacy matters here because hormone results are sensitive. Kantesti’s workflow is GDPR-aligned, and in my view that is not a side detail when someone uploads fertility, menopause, contraception or sexual-health related labs.
When a female testosterone result needs medical care
A female testosterone result needs medical care when it is markedly high, rapidly changing, paired with new virilizing symptoms, or inconsistent with the patient’s clinical picture. Total testosterone above 150–200 ng/dL or DHEA-S above about 700 µg/dL should not be ignored.
Same-week review is sensible for rapid voice deepening, new severe hirsutism, sudden scalp hair loss, clitoromegaly, unexplained muscle gain or a testosterone result more than 2–3 times the upper female range. These findings are uncommon, but when they appear, speed matters.
Borderline results can usually be repeated rather than rushed. If total testosterone is 72 ng/dL on an immunoassay, symptoms are mild and SHBG is unknown, I would rather repeat by LC-MS/MS with SHBG than label someone with a lifelong endocrine condition.
Dr Thomas Klein and Kantesti’s clinical reviewers treat hormone interpretation as risk sorting, not remote diagnosis. Our medical advisory board supports that approach: identify red flags, explain uncertainty, and help patients ask the right next question at the right time.
Frequently Asked Questions
What is the normal testosterone range for women?
The usual total testosterone normal range for women is roughly 15–70 ng/dL, or 0.5–2.4 nmol/L, in many adult reference intervals. Free testosterone is often about 0.1–6.4 pg/mL, but the method matters a lot. LC-MS/MS is preferred for total testosterone in women because routine immunoassays can be inaccurate at low female concentrations.
Does testosterone change during the menstrual cycle?
Testosterone can rise around ovulation, and some women show a mid-cycle increase of about 10–30% compared with early follicular levels. For repeat testing, cycle days 2–5 are often easier to compare when assessing acne, hirsutism or irregular periods. A result drawn on day 14 should not be compared casually with one drawn on day 3.
Can total testosterone be normal but free testosterone high?
Yes, total testosterone can be normal while free testosterone is high if SHBG is low. SHBG is commonly about 30–120 nmol/L in nonpregnant adults, and values near 15–25 nmol/L can increase the free hormone fraction. This pattern is common in insulin resistance, PCOS and some medication contexts.
How does birth control affect female testosterone levels?
Combined estrogen-containing birth control usually raises SHBG and lowers free testosterone, often by about 50–60%. Total testosterone may look normal or only mildly changed, while free testosterone becomes much lower. After stopping combined contraception, SHBG may take 8–12 weeks to settle toward a new baseline.
What is a concerning high testosterone level in women?
Total testosterone above 150–200 ng/dL in a woman is concerning and should be reviewed promptly, especially with rapid hair growth, voice deepening or sudden scalp hair loss. DHEA-S above about 700 µg/dL can suggest a strong adrenal contribution. Mild elevations such as 70–100 ng/dL are more often seen with PCOS, low SHBG or assay variation.
Is low testosterone in women a proven diagnosis?
Low testosterone in women is not diagnosed by one universal cutoff because symptoms overlap with thyroid disease, iron deficiency, depression, poor sleep and medication effects. A total testosterone below about 15 ng/dL may be low for many adults, but treatment decisions should be clinical. The strongest evidence for testosterone therapy is limited to selected postmenopausal women with hypoactive sexual desire disorder.
Which testosterone test is best for women?
The best first-line testosterone test for women is usually total testosterone measured by LC-MS/MS, paired with SHBG and albumin so calculated free testosterone can be estimated. Direct free testosterone immunoassays can be unreliable at low female levels. If the result is unexpected, repeat testing with the same lab and method is often more useful than reacting to one flagged value.
Get AI-Powered Blood Test Analysis Today
Join over 2 million users worldwide who trust Kantesti for instant, accurate lab test analysis. Upload your blood test results and receive comprehensive interpretation of 15,000+ biomarkers in seconds.
📚 Referenced Research Publications
Klein, T., Mitchell, S., & Weber, H. (2026). B Negative Blood Type, LDH Blood Test & Reticulocyte Count Guide. Kantesti AI Medical Research.
Klein, T., Mitchell, S., & Weber, H. (2026). Diarrhea After Fasting, Black Specks in Stool & GI Guide 2026. Kantesti AI Medical Research.
📖 External Medical References
Davis SR et al. (2019). Global consensus position statement on the use of testosterone therapy for women. Journal of Clinical Endocrinology & Metabolism.
⚕️ Medical Disclaimer
This article is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider for diagnosis and treatment decisions.
E-E-A-T Trust Signals
Experience
Physician-led clinical review of lab interpretation workflows.
Expertise
Laboratory medicine focus on how biomarkers behave in clinical context.
Authoritativeness
Written by Dr. Thomas Klein with review by Dr. Sarah Mitchell and Prof. Dr. Hans Weber.
Trustworthiness
Evidence-based interpretation with clear follow-up pathways to reduce alarm.